DBV Technologies (DBVT) Current Taxes (2015 - 2019)

DBV Technologies (DBVT) posted Current Taxes of $228098.7 for Q2 2019, down 55.39% sequentially from $511345.6 in Q4 2018.

DBV Technologies (DBVT) Current Taxes (2015 - 2019) Analysis & Trends

DBV Technologies has reported Current Taxes for 5 years, with the latest figure at $228098.7 in Q2 2019.

Quarterly Current Taxes changed N/A year-over-year to $228098.7 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $228098.7 (changed N/A YoY) and the FY2018 annual result came in at $511345.6, up 5.79% from the prior year.
Current Taxes fell to $228098.7 in Q2 2019 per DBVT's latest filing, from $511345.6 in the prior quarter.
Over five years, Current Taxes peaked at $544181.0 in Q4 2016 and troughed at $228098.7 in Q2 2019.
A 5-year average of $442572.0 and a median of $503941.1 in 2017 frame the typical range for Current Taxes.
The sharpest annual moves came in 2016 and 2017: Current Taxes advanced 27.95% in 2016, then dropped 7.39% in 2017.
Over 5 years, Current Taxes stood at $425293.5 in 2015, then grew by 27.95% to $544181.0 in 2016, then decreased by 7.39% to $503941.1 in 2017, then advanced by 1.47% to $511345.6 in 2018, then tumbled by 55.39% to $228098.7 in 2019.
According to Business Quant data, Current Taxes over the past three periods registered $228098.7, $511345.6, and $503941.1 for Q2 2019, Q4 2018, and Q4 2017 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	DBV Technologies	6.08 Bn	5.90 Bn	-	-

Download Data